| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/02/2008 | CA2194582C Novel process for the production of biologically active dimeric protein |
| 09/02/2008 | CA2175577C Receptor on the surface of activated t-cells: acts-4 |
| 09/02/2008 | CA2146973C Uses of tgf-.beta. receptor fragment as a therapeutic agent |
| 09/01/2008 | CA2580100A1 Treatment of endothelial dysfunction in diabetic patients |
| 08/28/2008 | WO2008103812A1 Compositions and methods for diagnosing and treating endometriosis |
| 08/28/2008 | WO2008103767A1 Treatment of conditions related to shock |
| 08/28/2008 | WO2008103538A1 Treating adhd and other diseases involving inflammation |
| 08/28/2008 | WO2008103471A2 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease |
| 08/28/2008 | WO2008103409A2 Compositions of chloroquine coupled to antibodies and to other proteins with methods for their synthesis |
| 08/28/2008 | WO2008103397A1 Suppression of allergic inflammation by ascaris aba-1 antigen |
| 08/28/2008 | WO2008103392A2 Modulation of nkt cell activity with antigen-loaded cdid molecules |
| 08/28/2008 | WO2008103380A2 Hepatitis b virus compositions and methods of use |
| 08/28/2008 | WO2008103369A2 Composition and method for cancer treatment using targeted carbon nanotubes |
| 08/28/2008 | WO2008103301A2 Treatment of the eye using macrophages and/or agents able to affect blood vessel morphology |
| 08/28/2008 | WO2008103191A1 Rnai methods and compositions for stimulating proliferation of cells with adherent junctions |
| 08/28/2008 | WO2008103146A2 Treating atherosclerosis |
| 08/28/2008 | WO2008103044A1 Non-natural recombinant gelatins with enhanced functionality |
| 08/28/2008 | WO2008103043A1 Rgd containing recombinant gelatin |
| 08/28/2008 | WO2008103042A1 Recombinant xrgd-enriched gelatins having high stability |
| 08/28/2008 | WO2008103041A1 Recombinant gelatins |
| 08/28/2008 | WO2008102912A1 Target protein and target gene for drug discovery, and screening method |
| 08/28/2008 | WO2008102849A1 Hgf preparation |
| 08/28/2008 | WO2008102783A1 Hair regrowth promoter |
| 08/28/2008 | WO2008102557A1 Peptide vaccines for cancers expressing tumor-associated antigens |
| 08/28/2008 | WO2008102452A1 Hgf preparation |
| 08/28/2008 | WO2008102233A1 Integrin targeted cyclopeptide ligands, their preparation and use |
| 08/28/2008 | WO2008101951A1 Combination therapy using tnf and alfa-galactosyl ceramide |
| 08/28/2008 | WO2008101680A1 Erythropoietin fusion protein |
| 08/28/2008 | WO2008101415A1 Recombinant chimeric protein of neutrophil inhibitory factor and hirugen and medicament composition thereof |
| 08/28/2008 | WO2008101406A1 Modified mutant collagenase and it's use in fat melting and in scar reduction |
| 08/28/2008 | WO2008101349A1 Recombinant viral vectors for prevention and protection against alphavirus infection |
| 08/28/2008 | WO2008101300A1 Composition and method for the treatment or prevention of spinal disorders |
| 08/28/2008 | WO2008084040A8 Use of mage a3-protein d fusion antigen in immunotherapy combined with surgery, chemotherapy or radiotherapy for the treatment of cancer |
| 08/28/2008 | WO2008083239A3 Compositions and methods for stimulating an immune response |
| 08/28/2008 | WO2008079995A3 Conjugate of natriuretic peptide and antibody constant region |
| 08/28/2008 | WO2008070833A9 Use of sh2 stat3/stat1 peptidomimetices as anticancer drugs |
| 08/28/2008 | WO2008070353A3 Tissue plasminogen activator variant uses |
| 08/28/2008 | WO2008067071A3 Immune system programming through b7-dc |
| 08/28/2008 | WO2008057609A8 Methods of treating neuronal disorders using mntf peptides and analogs thereof |
| 08/28/2008 | WO2008047364A3 Method and pharmacological composition for the diagnosis and treatment of male sub-fertility |
| 08/28/2008 | WO2008031032A3 Compounds for and methods of treating insulin resistance and inflammation |
| 08/28/2008 | WO2008014200A3 Cyclosporin compositions |
| 08/28/2008 | WO2008010980A3 Tat-049 and methods of assessing and treating cancer |
| 08/28/2008 | WO2008002971A3 Methods and compositions for the treatment of gastrointestinal disorders |
| 08/28/2008 | WO2007150077A8 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 08/28/2008 | WO2007112069A3 Endothelin and endothelin receptor agonists in the treatment of metabolic diseases |
| 08/28/2008 | WO2007098099A3 Method of treating a subject suffering from degenerative disc disease using a matrix metalloprotease inhibitor |
| 08/28/2008 | WO2007081647A3 Zinc finger domains specifically binding agc |
| 08/28/2008 | WO2006113792A3 Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease |
| 08/28/2008 | WO2006113782A3 Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof |
| 08/28/2008 | US20080208354 Solid Precursor For the Preparation of a Pasty Bone Replacement Material By Admixture of a Liquid |
| 08/28/2008 | US20080208167 Methods and compositions to treat myocardial conditions |
| 08/28/2008 | US20080207883 Platelet Derived Growth Factor (PDGF) Nucleic Acid Ligand Complexes |
| 08/28/2008 | US20080207877 Granulocyte cell stimulating factor (G-CSF), erythropoietin, interferon, and growth hormone |
| 08/28/2008 | US20080207580 Method of treating immune pathologies with low dose estrogen |
| 08/28/2008 | US20080207548 Immunogenic polynucleotides, expression vectors, antigen presenting host cells, diagnostic kits; cancer vaccines |
| 08/28/2008 | US20080207547 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080207546 Rna aptamers and methods for identifying the same |
| 08/28/2008 | US20080207543 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
| 08/28/2008 | US20080207531 Milk or whey is microfiltrated or heat treated; depositing on a cation exchange resin; washing cation exchange resin with demineralized water; elution with brine solutions of increasing conductivity; concentration by ultrafiltration, sterilization, spray drying; psoriasis, autoimmune diseases |
| 08/28/2008 | US20080207530 Tritoqualine or isomer, alpha-fluoromethylhistidine, 3-methoxy-5,7,3',4'-tetrahydroxyflavan, naringenin, cyanidanol-3, His-Phe dipeptide, 4-imidazolyl-3-amino-2-butanone, epigallocatechin gallate and other catechins; |
| 08/28/2008 | US20080207529 Isolated Dipeptides with Ace Inhibitor Effect |
| 08/28/2008 | US20080207528 Administering derivatives of 4-(3-pyrrolidinyloxy)quinoline |
| 08/28/2008 | US20080207527 Bicyclic isophthalamide derivatives such as N1-(5-hydroxy-8-(1-(isopropylamino)-3-methyl-1-oxobutan-2-ylamino)-2,7-dimethyl-8-oxooctan-4-yl)-5-(N-methylmethylsulfonamido)-N3-(1-phenylethyl)isophthalamide; Alzheimer's disease |
| 08/28/2008 | US20080207526 Synthetic peptides and methods of use for autoimmune disease therapies |
| 08/28/2008 | US20080207525 Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents; bioavailability; coupling; chemical intermediates |
| 08/28/2008 | US20080207524 Medicinal preparations for treating sex hormone-dependent diseases |
| 08/28/2008 | US20080207523 Compounds as aptamer-dimers and their uses in diagnosis and therapy |
| 08/28/2008 | US20080207522 Antimicrobial Peptides |
| 08/28/2008 | US20080207521 Polypeptide encoding amino acid sequence including MDGCEL (formylated Met-Asp-Gly-Cys-Glu-Leu) hexapeptide; antitumor and antimetastatic agents for treatment of breast, colon, thyroid, and nervous system cancer; mimic effects of Wnt-5a protein; increased adhesion impairs cancer cell migration |
| 08/28/2008 | US20080207520 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 08/28/2008 | US20080207519 Administering a p38 MAP kinase phosphorylation inhibitor selected from SB202190, SB203580, RWJ 67657, BIRB796, 681323, SCIO-469, SCIO-323, VX-702, and VX-745; skin and pemphigoid autoimmune blistering disorders; inhibiting heat shock protein pathway; |
| 08/28/2008 | US20080207518 Peptide analog with substitutions useful for therapy and prophylaxis of diseases and disorders related to ACTH, ACTH receptors or corticosteroid secretion, such as premature labor and Cushing's Disease; veterinary medicine, agriculture, aquaculture |
| 08/28/2008 | US20080207517 SELECTIVE INHIBITION OF NF-kappaB ACTIVIATION BY PEPTIDES DESIGNED TO DISRUPT NEMO OLIGOMERIZATION |
| 08/28/2008 | US20080207516 Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer |
| 08/28/2008 | US20080207515 Promotion of Epithelial Regeneration |
| 08/28/2008 | US20080207514 Drug delivery agents of N-([2-hydroxybenzoyl- or 2-hydroxynaphthoyl]-amino)alkanoic acid derivatives or salts; phenoxyalkanoic acid or salts; increased bioavailability; hyperglycemic agents |
| 08/28/2008 | US20080207513 Compositions For Buccal Delivery of Human Growth Hormone |
| 08/28/2008 | US20080207512 Methods for Treating Obesity and Obesity Related and Disorders |
| 08/28/2008 | US20080207511 Isolated polypeptide comprising amino acid sequence encoded by polynucleotide; physiologically acceptable carriers and immunostimulants |
| 08/28/2008 | US20080207510 Modified vitamin k-dependent polypeptides |
| 08/28/2008 | US20080207509 Scaffold |
| 08/28/2008 | US20080207508 Treatment of Fungal and/or Protist Infections |
| 08/28/2008 | US20080207507 Hypoglycemic agents; antidiabetic agents ; hypotensive agents; cardiovascular disorders; strokes; antiinflammatory agents; antiulcer agents; glucangon-like peptide |
| 08/28/2008 | US20080207506 Nucleic acid sequence coding Mammastatin; protein useful in diagnosis, therapy fo breast cancer ; antigrowth agents |
| 08/28/2008 | US20080207505 Diuretics; hypotensive agents; congestive heart failure; stimulate cyclic guanosine 3",5"-monophosphate |
| 08/28/2008 | US20080207504 SECRETED FRIZZLED RELATED PROTEIN, sFRP, FRAGMENTS AND METHODS OF USE THEREOF |
| 08/28/2008 | US20080207503 Composition and Treatment Methods for Coronary Artery Disease |
| 08/28/2008 | US20080207502 Anti-Angiogenic Peptides and Methods of Use Thereof |
| 08/28/2008 | US20080207501 Therapy for metabolism disorders, cardiovascular disorders, obesity, antidiabetic agents |
| 08/28/2008 | US20080207500 Propiomelanocortin and corticotropin releasing factor peptide; therapy for cancer, multiple sclerosis, nervous system disorders |
| 08/28/2008 | US20080207499 Rage-related methods for treating and preventing diabetic retinopathy |
| 08/28/2008 | US20080207498 Methods for Treating Alzheimer's Disease |
| 08/28/2008 | US20080207497 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 08/28/2008 | US20080207496 Mixture of staurosporine and drug for transplant rejection |
| 08/28/2008 | US20080207495 therapeutic methods, compositions, and medicaments related to cyclosporine. |
| 08/28/2008 | US20080207494 Cyclosporin Compositions |
| 08/28/2008 | US20080207493 Moderator of melanocortin receptor ; delay diabetes |
| 08/28/2008 | US20080207492 Crossing blood-brain barrier; central nervous system disorders; psychological disorders; behavioral disorders |
| 08/28/2008 | US20080207491 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |